Cargando…

Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor in adults. Despite multimodal therapy, median survival is poor at 12–15 months. At the molecular level, radio-/chemoresistance and resulting tumor progression are attributed to a small fraction of tumor cells, termed glio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evers, Lara, Schäfer, Agnes, Pini, Raffaella, Zhao, Kai, Stei, Susanne, Nimsky, Christopher, Bartsch, Jörg W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953941/ https://www.ncbi.nlm.nih.gov/pubmed/36831894 http://dx.doi.org/10.3390/brainsci13020350

Ejemplares similares

Dysregulation of MicroRNAs in cancer
por: Chen, Pai-Sheng, et al.
Publicado: (2012)

Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
por: Zhao, Kai, et al.
Publicado: (2021)

Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide
por: Otte, Katharina, et al.
Publicado: (2022)

Role of microRNAs in glioblastoma
por: Chen, Ming, et al.
Publicado: (2021)

Identification of dysregulated microRNAs in canine malignant melanoma
por: Ushio, Norio, et al.
Publicado: (2019)

MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
por: Catanesi, Mariano, et al.
Publicado: (2020)

Dysregulated CD4+ T Cells and microRNAs in Myocarditis
por: Wang, Jing, et al.
Publicado: (2020)

MicroRNAs Dysregulation and Metabolism in Multiple System Atrophy
por: Xiang, Chunchen, et al.
Publicado: (2019)

Emerging Roles of Dysregulated MicroRNAs in Myasthenia Gravis
por: Wang, Lin, et al.
Publicado: (2020)

Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival
por: Sana, Jiri, et al.
Publicado: (2018)

Clinical implications of microRNAs in human glioblastoma
por: Mizoguchi, Masahiro, et al.
Publicado: (2013)

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
por: Shea, Amanda, et al.
Publicado: (2016)

The Role of microRNAs in Multidrug Resistance of Glioblastoma
por: Mahinfar, Parvaneh, et al.
Publicado: (2022)

Bioinformatics analysis of dysregulated microRNAs in the nipple discharge of patients with breast cancer
por: Zhang, Kai, et al.
Publicado: (2017)

Dysregulation of MicroRNAs in Colonic Field Carcinogenesis: Implications for Screening
por: Kunte, Dhananjay P., et al.
Publicado: (2012)

Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer
por: Huang, Po-Shuan, et al.
Publicado: (2021)

The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer—An Update
por: Choi, Pui-Wah, et al.
Publicado: (2022)

MicroRNAs Dysregulation as Potential Biomarkers for Early Diagnosis of Endometriosis
por: Ghasemi, Fahimeh, et al.
Publicado: (2022)

The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its Aggressiveness
por: Schäfer, Agnes, et al.
Publicado: (2022)

Identifying Hedgehog Signaling Specific MicroRNAs in Glioblastomas
por: Gu, Wentao, et al.
Publicado: (2014)

Differential expression of microRNAs as predictors of glioblastoma phenotypes
por: Bradley, Barrie S, et al.
Publicado: (2014)

Differential Effects of MicroRNAs on Glioblastoma Growth and Migration
por: Jeansonne, Duane, et al.
Publicado: (2013)

MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in obstructive sleep apnea patients
por: Li, Kun, et al.
Publicado: (2017)

Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis
por: Stillger, Maren Nicole, et al.
Publicado: (2023)

Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients
por: Camkurt, Mehmet Akif, et al.
Publicado: (2016)

Identification of microRNAs with Dysregulated Expression in Status Epilepticus Induced Epileptogenesis
por: de Araújo, Mykaella Andrade, et al.
Publicado: (2016)

Uterine fluid microRNAs are dysregulated in women with recurrent implantation failure
por: von Grothusen, Carolina, et al.
Publicado: (2022)

Smoking-related dysregulation of plasma circulating microRNAs: the Rotterdam study
por: Karabegović, Irma, et al.
Publicado: (2023)

microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
por: Makowska, Marianna, et al.
Publicado: (2023)

Intratumour heterogeneity in microRNAs expression regulates glioblastoma metabolism
por: Alfardus, Huda, et al.
Publicado: (2021)

Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease
por: Zhong, Zhixiong, et al.
Publicado: (2018)

Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling
por: Chen, Junqing, et al.
Publicado: (2018)

Epigenetic alteration and microRNA dysregulation in cancer
por: Suzuki, Hiromu, et al.
Publicado: (2013)

Dysregulated Expression Profiles of MicroRNAs of Experimentally Induced Cerebral Aneurysms in Rats
por: Lee, Hyung-Jin, et al.
Publicado: (2013)

Identification of microRNAs dysregulated in cellular senescence driven by endogenous genotoxic stress
por: Nidadavolu, Lolita S., et al.
Publicado: (2013)

Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
por: Freischmidt, Axel, et al.
Publicado: (2013)

MicroRNAs implicated in dysregulation of gene expression following human lung transplantation
por: Zhang, Wei, et al.
Publicado: (2013)

The MAPK-Signaling Pathway in Colorectal Cancer: Dysregulated Genes and Their Association With MicroRNAs
por: Slattery, Martha L, et al.
Publicado: (2018)

Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

Identification and validation of hub microRNAs dysregulated in esophageal squamous cell carcinoma
por: Sang, Chen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2c8kqggrtt5u81mak3bmfk75pp